We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRABW icon
3201
CALL
Grab Holdings Warrant
GRABW
$598K
$71K ﹤0.01%
19,993
OTLK icon
3202
Outlook Therapeutics
OTLK
$169M
$71K ﹤0.01%
2,014
-5,664
-74% -$177K
HYLN icon
3203
Hyliion Holdings
HYLN
$631M
$69K ﹤0.01%
+15,520
New +$68.5K
IGV icon
3204
PUT
iShares Expanded Tech-Software Sector ETF
IGV
$12.3B
$69K ﹤0.01%
+1,000
New +$68.7K
EQOS
3205
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$69K ﹤0.01%
30,647
-86,821
-74% -$165K
ORIC icon
3206
Oric Pharmaceuticals
ORIC
$1.23B
$67K ﹤0.01%
+12,647
New +$114K
EFTRW
3207
CALL
DELISTED
eFFECTOR Therapeutics, Inc. Warrant
EFTRW
$67K ﹤0.01%
16,661
TOUR
3208
Tuniu
TOUR
$56.9M
$65K ﹤0.01%
+7,553
New +$83.1K
IFRX icon
3209
InflaRx
IFRX
$249M
$63K ﹤0.01%
+34,353
New +$107K
CO
3210
DELISTED
Global Cord Blood Corporation
CO
$63K ﹤0.01%
+16,458
New +$68.3K
ICAD
3211
DELISTED
iCAD Inc
ICAD
$62K ﹤0.01%
13,669
-18,024
-57% -$90.7K
AVEO
3212
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$62K ﹤0.01%
+11,021
New +$45.4K
LOMA
3213
Loma Negra
LOMA
$1.34B
$60K ﹤0.01%
+10,392
New +$62.1K
CEI
3214
DELISTED
Camber Energy, Inc
CEI
$59K ﹤0.01%
+1,370
New +$50.2K
WPRT
3215
Westport Fuel Systems
WPRT
$32.9M
$58K ﹤0.01%
3,739
-21,042
-85% -$376K
KUKE
3216
DELISTED
Kuke Music
KUKE
$56K ﹤0.01%
+1,442
New +$56.1K
REVBW icon
3217
CALL
Revelation Biosciences Warrant
REVBW
$56K ﹤0.01%
50,000
PHLT
3218
DELISTED
Performant Healthcare Inc
PHLT
$54K ﹤0.01%
+17,352
New +$40.9K
ATIP
3219
DELISTED
ATI Physical Therapy, Inc.
ATIP
$54K ﹤0.01%
+579
New +$73.7K
ASHR icon
3220
CALL
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.53B
$52K ﹤0.01%
1,600
-130,800
-99% -$4.69M
TRVI icon
3221
Trevi Therapeutics
TRVI
$2.62B
$52K ﹤0.01%
+23,402
New +$24.2K
VLTA
3222
DELISTED
Volta Inc.
VLTA
$50K ﹤0.01%
+16,430
New +$79K
CURI icon
3223
CuriosityStream
CURI
$145M
$49K ﹤0.01%
16,814
-50,741
-75% -$204K
TLMD
3224
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$49K ﹤0.01%
+16,608
New +$36.6K
UBER icon
3225
PUT
Uber
UBER
$144B
$48K ﹤0.01%
+1,300
New +$46.7K

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.